<VariationArchive VariationID="288197" VariationName="NM_014270.5(SLC7A9):c.614dup (p.Asn206fs)" VariationType="Duplication" Accession="VCV000288197" Version="30" RecordType="classified" NumberOfSubmissions="10" NumberOfSubmitters="10" DateLastUpdated="2024-05-27" DateCreated="2016-12-06" MostRecentSubmission="2024-03-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="272434" VariationID="288197">
      <GeneList>
        <Gene Symbol="SLC7A9" FullName="solute carrier family 7 member 9" GeneID="11136" HGNC_ID="HGNC:11067" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="32830511" stop="32869767" display_start="32830511" display_stop="32869767" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="33321416" stop="33360682" display_start="33321416" display_stop="33360682" Strand="-" />
          </Location>
          <OMIM>604144</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_014270.5(SLC7A9):c.614dup (p.Asn206fs)</Name>
      <CanonicalSPDI>NC_000019.10:32862207:TTT:TTTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19q13.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="32862207" stop="32862208" display_start="32862207" display_stop="32862208" variantLength="1" positionVCF="32862207" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="33353113" stop="33353114" display_start="33353113" display_stop="33353114" variantLength="1" positionVCF="33353113" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <OtherNameList>
        <Name>p.Asn206GlufsX3</Name>
      </OtherNameList>
      <ProteinChange>N206fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.32862210dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.32862210dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.33353116dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.33353116dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008258.1" sequenceAccession="NG_008258" sequenceVersion="1" change="g.12570dup">
            <Expression>NG_008258.1:g.12570dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126335.2" sequenceAccession="NM_001126335" sequenceVersion="2" change="c.614dup">
            <Expression>NM_001126335.2:c.614dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001119807.1" sequenceAccession="NP_001119807" sequenceVersion="1" change="p.Asn206fs">
            <Expression>NP_001119807.1:p.Asn206fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001243036.2" sequenceAccession="NM_001243036" sequenceVersion="2" change="c.614dup">
            <Expression>NM_001243036.2:c.614dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001229965.1" sequenceAccession="NP_001229965" sequenceVersion="1" change="p.Asn206fs">
            <Expression>NP_001229965.1:p.Asn206fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014270.5" sequenceAccession="NM_014270" sequenceVersion="5" change="c.614dup" MANESelect="true">
            <Expression>NM_014270.5:c.614dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055085.1" sequenceAccession="NP_055085" sequenceVersion="1" change="p.Asn206fs">
            <Expression>NP_055085.1:p.Asn206fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA9358740" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="604144.0011" DB="OMIM" />
        <XRef Type="rs" ID="745319034" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014270.5(SLC7A9):c.614dup (p.Asn206fs) AND Cystinuria" Accession="RCV000286788" Version="17">
        <ClassifiedConditionList TraitSetID="1615">
          <ClassifiedCondition DB="MedGen" ID="C0010691">Cystinuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-11-16" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014270.5(SLC7A9):c.614dup (p.Asn206fs) AND not provided" Accession="RCV000788761" Version="16">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-05" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014270.5(SLC7A9):c.614dup (p.Asn206fs) AND SLC7A9-related disorder" Accession="RCV003417906" Version="5">
        <ClassifiedConditionList TraitSetID="90583">
          <ClassifiedCondition>SLC7A9-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-30" NumberOfSubmissions="10" NumberOfSubmitters="10" DateCreated="2016-12-06" MostRecentSubmission="2024-03-16">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11157794</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12371955</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15635077</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16834950</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16838140</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19782624</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21255007</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25109415</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25296721</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25964309</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="90583" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="72049" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SLC7A9-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">SLC7A9-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1615" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1217" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cystinuria, non-type I</ElementValue>
                <XRef ID="UWMG_9204648" DB="CSER _CC_NCGL, University of Washington" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cystinuria</ElementValue>
                <XRef ID="22232" DB="GeneTests" />
                <XRef ID="Cystinuria/2081" DB="Genetic Alliance" />
                <XRef ID="HP:0003131" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0009067" DB="MONDO" />
                <XRef ID="85020001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CYSTINURIA, TYPE I</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CYSTINURIA, TYPE II</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CYSTINURIA, TYPE III</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CSNU</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CSNU1</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CSNU3</ElementValue>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cystinuria is an autosomal disorder characterized by impaired epithelial cell transport of cystine and dibasic amino acids (lysine, ornithine, and arginine) in the proximal renal tubule and gastrointestinal tract. The impaired renal reabsorption of cystine and its low solubility causes the formation of calculi in the urinary tract, resulting in obstructive uropathy, pyelonephritis, and, rarely, renal failure (summary by Barbosa et al., 2012).</Attribute>
                <XRef Type="MIM" ID="220100" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6237" />
                <XRef ID="6237" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">21863055</ID>
              </Citation>
              <XRef ID="214" DB="Orphanet" />
              <XRef ID="C0010691" DB="MedGen" />
              <XRef ID="MONDO:0009067" DB="MONDO" />
              <XRef Type="MIM" ID="220100" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003131" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="26328" SubmissionDate="2017-03-02" DateLastUpdated="2017-03-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604144.0011_CYSTINURIA" title="SLC7A9, 1-BP INS, 799A_CYSTINURIA" />
        <ClinVarAccession Accession="SCV000026328" DateUpdated="2017-03-08" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 4 patients with cystinuria defined as mixed (type I/II) (see 220100), Leclerc et al. (2002) identified a 1-bp insertion (799insA) in exon 6 of the SLC7A9 gene, predicted to create a downstream termination signal. The mutation was heterozygous in all 4 patients and was found on type II alleles in 2 of the patients and on type III alleles in the other 2. Leclerc et al. (2002) suggested that type II and type III cystinuria may be caused by the same mutation and that other factors must therefore influence urinary cystine excretion.</Attribute>
              <Citation>
                <ID Source="PubMed">12371955</ID>
              </Citation>
              <XRef DB="OMIM" ID="220100" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC7A9" />
          </GeneList>
          <Name>SLC7A9, 1-BP INS, 799A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 799A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604144.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CYSTINURIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="724935" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-24" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="831849" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000411414" DateUpdated="2019-05-24" DateCreated="2016-12-06" Type="SCV" Version="3" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21255007</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12371955</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25296721</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15635077</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25964309</ID>
          </Citation>
          <Comment>The SLC7A9 c.614dupA (p.Asn206GlufsTer3) variant, also referred to as c.799insA, has been reported in five studies in a total of 33 individuals with cystinuria, including three homozygotes, eight compound heterozygotes, and 22 heterozygotes with varying disease types (Leclerc et al. 2002; Font-Llitjos et al. 2005; Barbosa et al. 2012; Rhodes et al. 2015; Halbritter et al. 2015). Control data are unavailable for this variant, which is reported at a frequency of 0.00017 in the European (non-Finnish) population of the Exome Aggregation Consortium. The p.Asn206GlufsTer3 variant results in a frameshift, and is predicted to truncate the protein. While cystinuria generally displays an autosomal recessive mode of inheritance, some heterozygous carriers of variants in the SLC7A9 gene have abnormal urinary amino acid patterns and an increased risk of kidney stones (Eggermann et al. 2012). Based on the evidence and due to the potential impact of frameshift variants, the p.Asn206GlufsTer3 variant is classified as pathogenic for cystinuria. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC7A9" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="CT" referenceAllele="C" start="33353113" stop="33353113" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014270.4:c.614dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="220100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1816618" SubmissionDate="2019-05-08" DateLastUpdated="2019-07-30" DateCreated="2019-07-30">
        <ClinVarSubmissionID localKey="NM_014270.4:c.614dup|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000927996" DateUpdated="2019-07-30" DateCreated="2019-07-30" Type="SCV" Version="1" SubmitterName="Blueprint Genetics" OrgID="500188" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Blueprint Genetics Variant Classification Scheme</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8okxtmpf/blueprint_genetics_variant_classification_scheme.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014270.4:c.614dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Comment>Patient analyzed with Noonan Syndrome Panel</Comment>
        <SubmissionNameList>
          <SubmissionName>Blueprint Genetics 4/2019</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="655763" SubmissionDate="2016-11-03" DateLastUpdated="2019-07-30" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="46973_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000342240" DateUpdated="2019-07-30" DateCreated="2016-12-06" Type="SCV" Version="3" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-06-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation Type="general">
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC7A9" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="T" referenceAllele="-" start="33353113" stop="33353114" variantLength="2" />
            <GeneLocation>NM_014270.4:Ex6</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI024076" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://geneticslab.emory.edu/emvclass/emvclass.php?approved_symbol=SLC7A9</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL004</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1894778" SubmissionDate="2019-03-21" DateLastUpdated="2019-08-26" DateCreated="2019-08-26">
        <ClinVarSubmissionID localKey="77750510|Orphanet:ORPHA214" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000966984" DateUpdated="2019-08-26" DateCreated="2019-08-26" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-09-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15635077</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21255007</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25964309</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25296721</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12371955</ID>
          </Citation>
          <Comment>The p.Asn206GlufsX3 (NM_014270.4 c.614dupA) variant in SLC7A9 (also referred to as c.799insA or c.800?801insA in the literature) has been reported in at least 2 5 heterozygotes, 2 homozygotes, and 2 compound heterozygotes with cystinuria (Le clerc 2002, Font-Llitjos 2005, Barbosa 2012, Rhodes 2015, and Halbritter 2015). Twenty one heterozygotes were noted to have non-type I cystinuria (heterozygotes with moderate to high excretion of cystine in urine and risk of forming urinary tract stones) (Font-Llitjos 2005, Barbosa 2012, Halbritter 2015). This variant has also been reported in ClinVar (Variation ID#288197), as pathogenic by two la boratories. It has been identified in 0.024% (30/126,648) of European chromosom es by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs745319034). This variant is predicted to cause a frameshift, which alte rs the protein?s amino acid sequence beginning at position 206 and leads to a pr emature termination codon 3 amino acids downstream. This alteration is then pred icted to lead to a truncated or absent protein. Loss of function of the SLC7A9 g ene is an established disease mechanism in cystinuria. Variants associated with non-type I cystinuria, such as this variant, are inherited in an autosomal domin ant manner with incomplete penetrance and cause more severe disease in the homoz ygous or compound heterozygous state. In summary, although additional studies a re required to fully establish its clinical significance, the p.Asn206GlufsX3 va riant is pathogenic for cystinuria in an autosomal dominant manner with incompl ete penetrance based on its occurrence in affected individuals and a predicted n ull effect.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC7A9" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_014270.4:EXON 6</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_014270.4:c.614dupA</Name>
            <Name>p.Asn206GlufsX3</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.33353113_33353114insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA214" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348959</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1844767" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="2161704|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000950666" DateUpdated="2024-02-20" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11157794</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16838140</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25296721</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12371955</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15635077</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16834950</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19782624</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21255007</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25109415</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25296721</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25964309</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asn206Glufs*3) in the SLC7A9 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC7A9 are known to be pathogenic (PMID: 11157794, 16838140, 25296721). This variant is present in population databases (rs745319034, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with cystinuria in the heterozygous state (PMID: 12371955, 15635077, 16834950, 19782624, 21255007, 25109415, 25296721, 25964309). It has also been observed to segregate with disease in related individuals. This variant is also known as 799insA and c.800-801insA. ClinVar contains an entry for this variant (Variation ID: 288197). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC7A9" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.33353113_33353114insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3448032" SubmissionDate="2021-07-09" DateLastUpdated="2021-07-18" DateCreated="2021-07-18">
        <ClinVarSubmissionID localKey="NM_001126335.1:c.614dup|OMIM:220100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001752556" DateUpdated="2021-07-18" DateCreated="2021-07-18" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC7A9" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001126335.1:c.614dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="220100" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>This variant has been detected in individual(s) who were sent for testing of Renasight - kidney gene panel.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB9977930</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3956010" SubmissionDate="2022-10-19" DateLastUpdated="2023-03-04" DateCreated="2021-11-20">
        <ClinVarSubmissionID localKey="GDXSV:244138" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002015431" DateUpdated="2023-03-04" DateCreated="2021-11-20" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Observed in multiple unrelated patients from different ethnic backgrounds with type II and type III cystinuria or with cystinuria and nephrolithiasis in published literature (Leclerc et al., 2002; Halbritter et al., 2015); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 12371955, 26990548, 25296721, 30609409, 29431110, 28717662)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC7A9" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:1944466</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014270.4:c.614dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_135_20221019054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_71_20211117054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3967082" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="a16a95a179c306297061a31e84b227552fba51fdb4ad0d3417d50585921f2714|OMIM:220100" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002020729" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014270.5:c.614dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="220100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7691541" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="1468407|SLC7A9-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004107695" DateUpdated="2024-03-16" DateCreated="2023-11-20" Type="SCV" Version="2" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The SLC7A9 c.614dupA variant is predicted to result in a frameshift and premature protein termination (p.Asn206Glufs*3). This common pathogenic SLC7A9 variant in the heterozygous state has been reported to cause moderate or severe cystinuria in different families, suggesting an autosomal dominant mode of inheritance (reported as 799insA at Leclerc et al. 2002. PubMed ID: 12371955). This variant has also been reported in the homozygous or compound heterozygous state in many unrelated individuals to cause cystinuria (Rhodes et al. 2015. PubMed ID: 25964309; Bisceglia et al. 2010. PubMed ID: 19782624; Barbosa et al. 2011. PubMed ID: 21255007). In summary, the c.614dup is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC7A9" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014270.4:c.614dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SLC7A9-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3956010" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1894778" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA214" MappingRef="Orphanet">
        <MedGen CUI="C0010691" Name="Cystinuria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7691541" TraitType="Disease" MappingType="Name" MappingValue="SLC7A9-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="SLC7A9-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3448032" TraitType="Disease" MappingType="XRef" MappingValue="220100" MappingRef="OMIM">
        <MedGen CUI="C0010691" Name="Cystinuria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="724935" TraitType="Disease" MappingType="XRef" MappingValue="220100" MappingRef="OMIM">
        <MedGen CUI="C0010691" Name="Cystinuria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1816618" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1844767" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="26328" TraitType="Disease" MappingType="Name" MappingValue="CYSTINURIA" MappingRef="Preferred">
        <MedGen CUI="C0010691" Name="Cystinuria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3967082" TraitType="Disease" MappingType="XRef" MappingValue="220100" MappingRef="OMIM">
        <MedGen CUI="C0010691" Name="Cystinuria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="655763" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

